Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
CCOP - Southern Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
CCOP - Southern Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
North Shore University Hospital
mi
from
Manhasset, NY
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
The New York Presbyterian Hospital - Cornell Campus
mi
from
New York, NY
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
The New York Presbyterian Hospital - Cornell Campus
mi
from
New York, NY
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Mount Sinai Medical Center, NY
mi
from
New York, NY
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Mount Sinai Medical Center, NY
mi
from
New York, NY
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
mi
from
Syracuse, NY
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
mi
from
Syracuse, NY
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Arthur G. James Cancer Hospital - Ohio State University
mi
from
Columbus, OH
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Arthur G. James Cancer Hospital - Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Rhode Island Hospital
mi
from
Providence, RI
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Medical University of South Carolina
mi
from
Charleston, SC
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
University of Tennessee, Memphis Cancer Center
mi
from
Memphis, TN
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
University of Tennessee, Memphis Cancer Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Vermont Cancer Center
mi
from
Burlington, VT
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Vermont Cancer Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Howard University Cancer Center at Howard University Hospital
mi
from
Washington,
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Howard University Cancer Center at Howard University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Kapiolani Medical Center at Pali Momi
mi
from
Aiea, HI
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Kapiolani Medical Center at Pali Momi
mi
from
Aiea, HI
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Leeward Radiation Oncology Center
mi
from
Ewa Beach, HI
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Leeward Radiation Oncology Center
mi
from
Ewa Beach, HI
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Cancer Research Center of Hawaii
mi
from
Honolula, HI
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Cancer Research Center of Hawaii
mi
from
Honolula, HI
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
OnCare Hawaii, Incorporated - Lusitana
mi
from
Honolulu, HI
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
OnCare Hawaii, Incorporated - Lusitana
mi
from
Honolulu, HI
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Queen's Cancer Institute at Queen's Medical Center
mi
from
Honolulu, HI
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Queen's Cancer Institute at Queen's Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Straub Clinic and Hospital, Incorporated
mi
from
Honolulu, HI
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Straub Clinic and Hospital, Incorporated
mi
from
Honolulu, HI
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
OnCare Hawaii, Incorporated - Kuakini
mi
from
Honolulu, HI
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
OnCare Hawaii, Incorporated - Kuakini
mi
from
Honolulu, HI
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
St. Francis Medical Center
mi
from
Honolulu, HI
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
St. Francis Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Kapiolani Medical Center for Women and Children
mi
from
Honolulu, HI
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Kapiolani Medical Center for Women and Children
mi
from
Honolulu, HI
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
St. Joseph Medical Center
mi
from
Bloomington, IL
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
St. Joseph Medical Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Graham Hospital
mi
from
Canton, IL
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Graham Hospital
mi
from
Canton, IL
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Memorial Hospital
mi
from
Carthage, IL
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Memorial Hospital
mi
from
Carthage, IL
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
St. Anthony's Memorial Hospital
mi
from
Effingham, IL
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
St. Anthony's Memorial Hospital
mi
from
Effingham, IL
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Eureka Community Hospital
mi
from
Eureka, IL
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Eureka Community Hospital
mi
from
Eureka, IL
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Galesburg Clinic, PC
mi
from
Galesburg, IL
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Galesburg Clinic, PC
mi
from
Galesburg, IL
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Galesburg Cottage Hospital
mi
from
Galesburg, IL
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Galesburg Cottage Hospital
mi
from
Galesburg, IL
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Mason District Hospital
mi
from
Havana, IL
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Mason District Hospital
mi
from
Havana, IL
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Hopedale Medical Complex
mi
from
Hopedale, IL
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Hopedale Medical Complex
mi
from
Hopedale, IL
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Joliet Oncology-Hematology Associates, Limited - West
mi
from
Joliet, IL
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Joliet Oncology-Hematology Associates, Limited - West
mi
from
Joliet, IL
Click here to add this to my saved trials